Largest route
ITA to USA$2.6BTrade Corridor Access Planner
Trade corridors for containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale
A reported trade view for HS 300439, with available observations through 2024.
Explore this productDisplayed routes
100Reported corridorsMedian distance
3,994 kmDisplayed routesLatest global trade
$44.3BYear: 2024Reported observations
Route access evidence
Routes ranked by latest reported trade value. Buyer-market and route fields are shown when reported.
| Route | Route trade | 5-year growth | Buyer imports | Supplier countries | Applied tariff | Distance |
|---|---|---|---|---|---|---|
| Italy to USA | $2.6B | +45.9% | $9.3B | 43 | 4.7% | 6,895 km |
| Austria to Switzerland, Liechtenstein | $1.9B | -0.9% | $2.7B | 48 | 0% | 685 km |
| Italy to United Kingdom | $1.5B | +122.1% | $3.0B | 53 | 0% | 1,438 km |
| Ireland to USA | $1.5B | +21.1% | $9.3B | 43 | 0% | 5,118 km |
| Italy to Germany | $1.3B | +60.9% | $2.8B | 58 | 0% | 1,146 km |
| Italy to France | $1.2B | +67.7% | $2.4B | 64 | 0% | 1,110 km |
| France to USA | $1.1B | +7% | $9.3B | 43 | 0% | 5,838 km |
| Denmark to China | $1.0B | +82.3% | $3.0B | 40 | 0.3% | 7,208 km |
| China to Denmark | $957.9M | +1,111.8% | $1.2B | 31 | 0% | 7,208 km |
| Germany to USA | $949.9M | +33% | $9.3B | 43 | 0% | 6,035 km |
| Italy to Belgium | $865.8M | -13.6% | $1.6B | 54 | 0% | 1,175 km |
| Denmark to Brazil | $754.5M | +54.5% | $1.2B | 35 | 0.3% | 10,432 km |
| Switzerland, Liechtenstein to USA | $648.6M | +7.2% | $9.3B | 43 | 0% | 6,272 km |
| Denmark to USA | $600.9M | -32.3% | $9.3B | 43 | 0% | 6,192 km |
| Denmark to United Kingdom | $542.0M | +40% | $3.0B | 53 | 0% | 960 km |
| Italy to Spain | $533.8M | +67.4% | $1.2B | 37 | 0% | 1,367 km |
| Denmark to Italy | $507.2M | +28.1% | $1.7B | 55 | 0% | 1,534 km |
| Denmark to Japan | $478.4M | +14.8% | $1.8B | 37 | 0% | 8,703 km |
| Switzerland, Liechtenstein to Netherlands | $464.4M | -3.2% | $899.8M | 56 | 0% | 628 km |
| Austria to USA | $441.9M | +8.2% | $9.3B | 43 | 0% | 6,799 km |
| Italy to China | $436.6M | +36.9% | $3.0B | 40 | 0.3% | 8,135 km |
| Germany to France | $404.1M | +20% | $2.4B | 64 | 0% | 440 km |
| France to Italy | $402.1M | -22.9% | $1.7B | 55 | 0% | 1,110 km |
| USA to Japan | $372.9M | +28.1% | $1.8B | 37 | 0% | 10,856 km |
| Germany to Japan | $367.9M | +21.1% | $1.8B | 37 | 0% | 9,298 km |
| United Kingdom to China | $364.5M | +18.9% | $3.0B | 40 | 0.3% | 8,151 km |
| Switzerland, Liechtenstein to Germany | $353.3M | +3.3% | $2.8B | 58 | 0% | 504 km |
| Canada to USA | $346.8M | +0.8% | $9.3B | 43 | 0% | 548 km |
| France to Germany | $317.9M | -0.3% | $2.8B | 58 | 0% | 440 km |
| Italy to Saudi Arabia | $317.9M | +343% | $824.6M | 44 | 0.1% | 3,685 km |
| Germany to China | $264.6M | +12.2% | $3.0B | 40 | 0.3% | 7,785 km |
| Denmark to Israel | $263.2M | +61% | $421.0M | 27 | 0.1% | 3,141 km |
| USA to Saudi Arabia | $240.1M | +52.6% | $824.6M | 44 | 0.1% | 10,527 km |
| Canada to Japan | $228.6M | +11.2% | $1.8B | 37 | 0% | 10,358 km |
| Denmark to Switzerland, Liechtenstein | $227.9M | +33.9% | $2.7B | 48 | 0% | 1,034 km |
| Germany to Spain | $225.7M | +16% | $1.2B | 37 | 0% | 1,479 km |
| China to France | $216.3M | +258.6% | $2.4B | 64 | 0% | 8,225 km |
| Italy to Switzerland, Liechtenstein | $215.5M | -3.3% | $2.7B | 48 | 0% | 693 km |
| Belgium to Italy | $211.5M | -20.7% | $1.7B | 55 | 0% | 1,175 km |
| USA to Mexico | $209.1M | +44.7% | $485.6M | 34 | 0.1% | 3,369 km |
Market reading
Which containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale trade routes matter most?
The leading reported route is Italy to USA, with trade value of $2.6B.
How to use this view
Start with the leading rows in the first table to compare the reported observations available for this view. The second table adds a related reported comparison.
Coverage extends to 2024. Missing values are shown as not reported.
Further comparison
Selected route history
Annual reported trade and change for the featured route.
| Year | Route trade | Year-on-year change | 3-year growth |
|---|---|---|---|
| 2010 | $133.9M | +16.6% | +20.5% |
| 2011 | $118.1M | -11.8% | +1.2% |
| 2012 | $125.9M | +6.6% | +3.1% |
| 2013 | $134.2M | +6.5% | +0.1% |
| 2014 | $111.9M | -16.6% | -1.8% |
| 2015 | $127.2M | +13.7% | +0.3% |
| 2016 | $200.5M | +57.6% | +14.3% |
| 2017 | $339.9M | +69.5% | +44.8% |
| 2018 | $330.5M | -2.8% | +37.5% |
| 2019 | $391.1M | +18.4% | +25% |
| 2020 | $609.0M | +55.7% | +21.5% |
| 2021 | $617.0M | +1.3% | +23.1% |
| 2022 | $869.4M | +40.9% | +30.5% |
| 2023 | $1.5B | +75.1% | +35.7% |
| 2024 | $2.6B | +69.9% | +61.2% |
Explore related views
Continue with another perspective on this product.
Latest observed year: 2024. Page updated 2026-08-14.
Source and date
Reported merchandise-trade observations for HS6 products. Coverage shown on this page: 1995-2024. Updated 2026-08-14.
Definitions
Trade value is reported in current US dollars. Unit value is trade value divided by reported quantity and is shown per metric ton where available. Growth is an annualized or year-on-year calculation from reported values.
Reading the data
“Not reported” means a value was not available for this view. Values can be revised as reporting is updated. See the methodology for coverage and classification details.